Pembrolizumab-related systemic myositis involving ocular and hindneck muscles resembling myasthenic gravis: a case report

BACKGROUND: Pembrolizumab is an immune-checkpoints inhibitor that enhances the immune response against cancer cells and therefore is useful for the treatment of several carcinomas. However, pembrolizumab sometimes perturbs the immune system resulting in various autoimmune neurological complications....

Descripción completa

Detalles Bibliográficos
Autores principales: Kamo, Hikaru, Hatano, Taku, Kanai, Kazuaki, Aoki, Nozomi, Kamiyama, Daiki, Yokoyama, Kazumasa, Takanashi, Masashi, Yamashita, Yuri, Shimo, Yasushi, Hattori, Nobutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681482/
https://www.ncbi.nlm.nih.gov/pubmed/31382909
http://dx.doi.org/10.1186/s12883-019-1416-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681482/
https://www.ncbi.nlm.nih.gov/pubmed/31382909
http://dx.doi.org/10.1186/s12883-019-1416-1

Ejemplares similares